UroGen Pharma (URGN)
Develops localized mitomycin therapies for low-grade urothelial cancers.
$41.04
vs last close−1.72 (−4.02%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 87.06% | 42.56M shares | |
|---|---|---|---|
| 199 holders · as of Jun 30, 2026 | |||
| Insiders | 0.27% | 131.3K shares | |
| 8 holders · as of Sep 9, 2026 | |||
| Other | 12.67% | 6.19M shares | |
| remainder | |||
48.88M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
199 holders · 42.56M shares · 42 new positions · 103 increased · 54 reduced · 23 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| RTW Investments, LP | 4.54M | 9.30% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 3.20M | 6.55% | +355.9K | Aug 7, 2026 |
| Morgan Stanley | 2.58M | 5.27% | +16.3K | Aug 13, 2026 |
| Kynam Capital Management, LP | 2.43M | 4.98% | +186.8K | Aug 14, 2026 |
| Jefferies Financial Group Inc. | 2.20M | 4.50% | 0 | Aug 17, 2026 |
| SG Americas Securities, LLC | 2.05M | 4.20% | +395.1K | Aug 7, 2026 |
| American Century Companies Inc | 1.69M | 3.45% | +48.1K | Aug 12, 2026 |
| Acorn Capital Advisors, LLC | 1.67M | 3.42% | 0 | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Phillip Grossincl. Adage Capital Management, L.P., Robert Atchinson | 8.87% | 3.74M | 13G | Nov 12, 2024 |
| BlackRock, Inc. | 5.90% | 2.50M | Nov 8, 2024 | |
| The Toronto-Dominion Bank | 5.40% | 2.62M | 13G | May 15, 2026 |
| Morgan Stanley | 5.40% | 2.49M | 13G | Aug 6, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 8, 2026 | Jason Drew Smithofficer: General Counsel | Sale | 1,519 | $42.54 | 53,141 |
| Sep 8, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 871 | $42.92 | 59,882 |
| Aug 20, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 60,677 | $47.05 | 59,086 |
| Jul 9, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 10,000 | $40.00 | 119,763 |
| Jun 22, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 10,000 | $35.01 | 129,763 |
| Jun 8, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 5,222 | $27.30 | 139,763 |
| May 8, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 10,000 | $30.00 | 134,985 |
| Feb 3, 2026 | Jason Drew Smithofficer: General Counsel | Sale · 3 lots | 7,479 | $19.69 | 51,326 |
| Feb 3, 2026 | Mark Schoenbergofficer: Chief Medical Officer | Sale · 3 lots | 7,373 | $19.69 | 144,985 |
| Nov 19, 2025 | Mark Schoenbergofficer: Chief Medical Officer | Sale | 10,000 | $25.00 | 139,025 |
House and Senate disclosures
Not reported.